Sadakatsu Ikeda on Muck Rack

Sadakatsu Ikeda

As seen in: Nature, MDPI
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Sadakatsu

Contact Sadakatsu, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Orchestration of B and T cells predicts prolonged survival after cancer immune checkpoint inhibitor therapy

|
By Yu Fujiwara, Shumei Kato, Daisuke Nishizaki, Hirotaka Miyashita, Suzanna M. Lee, Taylor Jensen, Paul DePietro, RJ Seager, Sadakatsu Ikeda, Razelle Kurzrock
| Nature Verified
Abstract Tertiary lymphoid structures (TLSs) facilitate tumor microenvironment immune interactions. While TLSs and their associated gene signatures correlate with better response to immune checkpoint inhibitors (ICIs), the complex transcriptomic interplay/co-regulation among these factors remains under investigation. We analyzed correlations between survival and transcriptome expression (35 immunoregulatory factors associated with B/T cells and TLSs) in 217 patients with ICI-treated solid tumors.
Open in Who Shared Issue with article?

Correction: Exploratory analysis of gene aberrations and chemotherapy response: findings from a real-world database in Japan

|
By Naoya Ishibashi, Masanori Tokunaga, Yusuke Kinugasa, Sadakatsu Ikeda, Takashi Kamatani, Satoru Aoyama
| Nature Verified
Correction to: British Journal of Cancer https://doi.org/10.1038/s41416-025-03281-1, published online 22 December 2025 In the originally published version of this Article, the images for Figure 1c and Figure 1d were inadvertently duplicated from Figure 1b. This has now been corrected and the accurate Figure 1c and Figure 1d are shown in the updated Figure 1. The article has been corrected. Figure 1.
Open in Who Shared View Duplicates (3) Issue with article?

Targeting MET Amplification: Opportunities and Obstacles in Therapeutic Approaches

|
By Yuichi Kumaki, Goshi Oda, Sadakatsu Ikeda
| MDPI
1. Introduction The MET gene, also referred to as c-MET, encodes a receptor tyrosine kinase (RTK) known as MET. This gene has garnered significant attention in the oncology field due to its pivotal role in tumorigenesis and metastasis [1].
Open in Who Shared Issue with article?
See all 4 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified